Muutke küpsiste eelistusi

Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease 2020 ed. [Pehme köide]

  • Formaat: Paperback / softback, 234 pages, kõrgus x laius: 254x178 mm, kaal: 470 g, 27 Illustrations, color; 11 Illustrations, black and white; VIII, 234 p. 38 illus., 27 illus. in color., 1 Paperback / softback
  • Sari: Advances in Experimental Medicine and Biology 1276
  • Ilmumisaeg: 25-Jul-2021
  • Kirjastus: Springer Verlag, Singapore
  • ISBN-10: 9811560846
  • ISBN-13: 9789811560842
Teised raamatud teemal:
  • Pehme köide
  • Hind: 169,14 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 198,99 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Paperback / softback, 234 pages, kõrgus x laius: 254x178 mm, kaal: 470 g, 27 Illustrations, color; 11 Illustrations, black and white; VIII, 234 p. 38 illus., 27 illus. in color., 1 Paperback / softback
  • Sari: Advances in Experimental Medicine and Biology 1276
  • Ilmumisaeg: 25-Jul-2021
  • Kirjastus: Springer Verlag, Singapore
  • ISBN-10: 9811560846
  • ISBN-13: 9789811560842
Teised raamatud teemal:
This book provides an up-to-date review of the fundamentals of lipid metabolism and its role in cardiovascular diseases. Focusing on lipid transfer proteins in the circulation and cells, the role of important lipid transporters, the effect of recently discovered lipid binding proteins, and the link between lipid metabolism disorders and cardiovascular diseases, it covers phospholipid transfer protein, cholesteryl ester transfer protein, lipopolysaccharide binding protein, microsomal triglyceride transfer protein, ABC binding cassette members, and more. The book offers graduate students and researchers a coherent overview of lipid transfer and transport, as well as the limitations of current research in the field, and promotes further studies on cardiovascular diseases, as well as pharmaceutical research on drug discovery based on lipid transfer, transport, and binding.
Chapter 1: Impact of Phospholipid Transfer Protein in Lipid Metabolism
and Cardiovascular Diseases.- Chapter 2: Cholesteryl Ester Transfer Protein
and Lipid Metabolism and Cardiovascular Diseases.- Chapter 3:
Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing
Protein in Lipid Metabolism and Cardiovascular Diseases.- Chapter 4:
Microsomal Triglyceride Transfer Protein: From Lipid Metabolism to Metabolic
Diseases.- Chapter 5: Circadian-Clock Regulation on Lipid Metabolism and
Metabolic Diseases.- Chapter 6: ABC Transporters, Cholesterol Efflux and
Implications for Cardiovascular Diseases.- Chapter 7: Apolipoprotein M:
research progress and clinical perspective.- Chapter 8: Recent Advances in
the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and
Disease.- Chapter 9: Proprotein Convertase Subtilisin/Kexin-type 9 and Lipid
Metabolism.- Chapter 10: LDL and HDL Oxidative Modification and
Atherosclerosis.- Chapter 11: Rare Diseases Related with Lipoprotein
Metabolism.- Chapter 12: Pre1 High Density Lipoprotein in Cardiovascular
Diseases.- Chapter 13: CGI-58: Versatile Regulator of Intracellular Lipid
Droplet Homeostasis.- Chapter 14: Mfsd2a, a physiologically important
lysolipid transporter in brain and eye.
Dr. Xian-Cheng Jiang (PhD) is a Distinguished Professor of State University of New York (SUNY). He is working at the Department of Cell Biology, SUNY Downstate Health Sciences University. His research focuses on lipid metabolism and  metabolic diseases, such as atherosclerosis, metabolic syndrome, obesity and liver steatosis, particularly how phospholipid metabolism influences plasma lipoprotein metabolism, cell membrane lipid composition and function, and the development of metabolic diseases.